| Dr Nathan William Kincaid, MD | |
|
203 W Pioneer Ave, Homer, AK 99603-7527 | |
| (907) 235-3225 | |
| (907) 235-3203 |
| Full Name | Dr Nathan William Kincaid |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 11 Years |
| Location | 203 W Pioneer Ave, Homer, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588008429 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 080536 (Georgia) | Secondary |
| 208600000X | Surgery | 185476 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Peninsula Hospital | Homer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Peninsula Hospital Inc | 5395636930 | 43 |
News Archive
Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that global contract research organization (CRO) Omnicare Clinical Research has attained Rave Accredited Plus, the most advanced level in Medidata's ASPire to Win® program for CROs and other service providers.
The COVID-19 pandemic is forcing national governments around the world to take actions they never dreamed they would take.
BioSante Pharmaceuticals, Inc. today announced the receipt of Orphan Drug designation for its Melanoma Cancer Vaccine in the treatment of stage IIb to IV melanoma, from the FDA's Office of Orphan Products Development. Melanoma is the most deadly form of skin cancer.
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
Aradigm Corporation today announced that it has entered into a Stock Purchase Agreement providing for the issuance by the Company of 26 million shares of the Company's common stock to Novo Nordisk A/S in a private placement as consideration for the termination of a promissory note in favor of Novo Nordisk under which approximately $9.1 million is currently outstanding, representing an effective price per share of $0.3505.
› Verified 7 days ago
| Entity Name | South Peninsula Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679566269 PECOS PAC ID: 5395636930 Enrollment ID: O20040323000583 |
News Archive
Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that global contract research organization (CRO) Omnicare Clinical Research has attained Rave Accredited Plus, the most advanced level in Medidata's ASPire to Win® program for CROs and other service providers.
The COVID-19 pandemic is forcing national governments around the world to take actions they never dreamed they would take.
BioSante Pharmaceuticals, Inc. today announced the receipt of Orphan Drug designation for its Melanoma Cancer Vaccine in the treatment of stage IIb to IV melanoma, from the FDA's Office of Orphan Products Development. Melanoma is the most deadly form of skin cancer.
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
Aradigm Corporation today announced that it has entered into a Stock Purchase Agreement providing for the issuance by the Company of 26 million shares of the Company's common stock to Novo Nordisk A/S in a private placement as consideration for the termination of a promissory note in favor of Novo Nordisk under which approximately $9.1 million is currently outstanding, representing an effective price per share of $0.3505.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nathan William Kincaid, MD 4300 Bartlett St, Homer, AK 99603-7000 Ph: (907) 235-3225 | Dr Nathan William Kincaid, MD 203 W Pioneer Ave, Homer, AK 99603-7527 Ph: (907) 235-3225 |
News Archive
Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that global contract research organization (CRO) Omnicare Clinical Research has attained Rave Accredited Plus, the most advanced level in Medidata's ASPire to Win® program for CROs and other service providers.
The COVID-19 pandemic is forcing national governments around the world to take actions they never dreamed they would take.
BioSante Pharmaceuticals, Inc. today announced the receipt of Orphan Drug designation for its Melanoma Cancer Vaccine in the treatment of stage IIb to IV melanoma, from the FDA's Office of Orphan Products Development. Melanoma is the most deadly form of skin cancer.
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.
Aradigm Corporation today announced that it has entered into a Stock Purchase Agreement providing for the issuance by the Company of 26 million shares of the Company's common stock to Novo Nordisk A/S in a private placement as consideration for the termination of a promissory note in favor of Novo Nordisk under which approximately $9.1 million is currently outstanding, representing an effective price per share of $0.3505.
› Verified 7 days ago
Rene L Alvarez, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 104 East Fairview Ave, Homer, AK 99603 Phone: 907-235-1010 Fax: 907-235-1099 | |
M Todd Boling, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 203 W Pioneer Ave, Suite 2, Homer, AK 99603 Phone: 907-235-3225 Fax: 907-235-3203 | |
Dr. James Paul Sayer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4209 Hohe Street, Homer, AK 99603 Phone: 907-235-7659 Fax: 907-235-6219 |